Recently sold
MS · Morgan Stanley
Updated ·
Against its published line
Above its line on the last close.
How to read this
The red mark is the published kill line — the price that would prove the thesis wrong. The dot is where the name closed on the last session; a dot left of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row reads well clear, with a hollow dot to show the figure is off the drawn scale. Rows run tightest first.
Kill line
A daily close below $170, which would take the shares under their whole October 2026 trading range. Q4 2026 Wealth Management net new assets far below Q3's $232.4 billion, or write-downs on private-credit or AI-compute loans, would also break the case.
Last pick Medium conviction, to : −0.8% against the S&P 500's −1.1%. Beat the S&P 500 · conviction cut below medium.
Catalyst (in 32 days)
How picks are graded →The thesis
Morgan Stanley's shares look more likely to trail the S&P 500 until the fourth-quarter report, expected around 14 January 2027, because a record wealth quarter has brought mostly target cuts and no recovery in the price. That report shows whether the record $232.4 billion of Wealth Management net new assets repeats and whether investment banking growth picks up from 2%.
The shares closed at $182.44 on 5 November 2026, 19.2% below their $225.92 52-week high and down 14.8% over three months, in adjusted daily closes. That close is lower than the $184.30 close on 30 October 2026, the day the shares went ex-dividend for the $1.15 quarterly payout.
Company news from 3 November to 5 November 2026 carried new mandates and a tokenization step, with no new results or guidance. The consensus target slipped to $211.50 across 26 analysts on 6 November 2026, from $213.27 across 25 on 22 October 2026, on the same site.
The narrative is maturing: the move toward wealth management is well known, and the record-flow quarter reported on 14 October 2026 was followed by a 14.8% three-month decline at the 5 November 2026 close. The view here would be shown wrong by several target raises that lift the StockAnalysis consensus back above $213.27 before the January report, or by the shares rising while the KBW Nasdaq Bank Index falls.
Bullish and bearish views on Morgan Stanley
The bull case on Morgan Stanley (MS), in brief: Equity trading revenues rose 41% to $5.8 billion. The bear case: Target cuts dominated after the report.
Bull case
- Equity trading revenues rose 41% to $5.8 billion.
- Large financing mandates keep arriving. Company news on 4 November 2026 said Morgan Stanley and Citi will manage Meta's first euro-denominated bond. Company news on 3 November 2026 reported a $2.3 billion Morgan Stanley debt offering tied to Baldwin, which a Bloomberg headline described as debt for a Dell family deal.
- Every published target sits above the price. StockAnalysis showed targets from $185 to $262 and a consensus Buy rating on 6 November 2026, against the $182.44 close on 5 November 2026. UBS's raise to $240 on 2 November 2026 is the first increase since JPMorgan's move to $198 after the report.
- Capital returns continue. The company repurchased $1.5 billion of shares in Q3 2026, declared a $1.15 quarterly dividend and reported a 14.9% Standardized common equity tier 1 (CET1) capital ratio at 30 September 2026, according to the 14 October 2026 release.
- New market plumbing is going live. Benzinga reported on 4 November 2026 that Morgan Stanley is tokenizing US stocks and Treasurys through the Depository Trust & Clearing Corporation's platform. Company news on 3 November 2026 said its investment management arm added Jiko's Treasury bill access to its CashInvest platform.
Bear case
- Target cuts dominated after the report. Between 15 October 2026 and 19 October 2026, Citigroup cut its target to $190, RBC Capital to $195, TD Cowen, Piper Sandler and Evercore ISI to $205, BMO Capital to $210, Wells Fargo to $217, BofA to $220 and Keefe, Bruyette & Woods to $230, Benzinga and StockAnalysis reported. Freedom Capital Markets followed with a cut to $210 from $245 on 23 October 2026, StockAnalysis shows.
- Returns slipped despite the beat. Return on tangible common equity (ROTCE) was 22.6% in Q3 2026 against 23.5% a year earlier, according to the 14 October 2026 release.
- Investment banking lagged trading. Investment banking revenues rose 2% to $2.2 billion in Q3 2026 and fixed income revenues fell 7% to $2.0 billion, while equity revenues rose 41%, according to the same release. A quarter led by equity trading is harder to repeat than one led by fees.
- Private-credit worries sit next to the wealth business. The North Haven Private Income Fund received repurchase requests for about 10.9% of its shares and capped repurchases at 5%, InvestmentNews reported in March 2026. Blackstone's 26 October 2026 press release also names Morgan Stanley among first-lien arrangers of a $63 billion package financing Broadcom hardware leased to Anthropic, a concentrated AI-compute exposure.
- Rates may move against bank shares. The Federal Reserve held its target range at 3.75%-4.00% in a 10-2 vote on 28 October 2026, with Governor Lisa Cook and Cleveland Fed President Beth Hammack dissenting in favour of a hike, CNBC reported.
Price setup
The shares closed at $182.44 on 5 November 2026, against a $225.92 52-week high. The 14-day relative strength index (RSI), a momentum gauge that runs from 0 to 100, stood at 52.7 on that date, which is neither stretched nor washed out. The close sits $2.56 under the lowest target on StockAnalysis, $185.
Crowding is not visible in the price: the shares are 19.2% below their high and down 14.8% over three months. The visible attention is light, such as a mention among the CNBC Halftime Report final trades on 5 November 2026, Benzinga reported. The company was repurchasing shares in Q3 2026 and no share issuance appears in company news, and the next report is not imminent.
The $170 level marks the point at which the shares would be under their whole October 2026 trading range in adjusted daily closes. A close there would mean the post-report decline had extended into new lows for the autumn.
Catalysts, next 30 days
No dated company event turned up for the 30 days to 6 December 2026. The next dated events follow because the case turns on them.
- 9 December 2026: Federal Reserve rate decision at the December meeting. Two officials dissented for a hike on 28 October 2026, and an increase would test whether bank shares can recover.
- ~31 December 2026, est.: Quarterly repurchase window at the North Haven Private Income Fund. Requests above the fund's 5% cap would keep private-credit worries attached to the wealth business.
- ~14 January 2027, est.: Q4 2026 results, before the US market opens. The report shows whether net new assets carry forward from $232.4 billion, whether investment banking growth improves from 2%, and whether equity revenues hold near $5.8 billion.
What would change the view
The case breaks if the January report shows Wealth Management net new assets far below Q3's $232.4 billion, or if private-credit or AI-compute loans bring write-downs. A sharp rise in the provision for credit losses tied to those loans would point the same way. In price terms, a daily close below $170 would take the shares under their whole October 2026 trading range.
The view that the shares trail the S&P 500 fails if analysts turn. Several raises that lift the StockAnalysis consensus target above $213.27 before January, or the shares rising while the KBW Nasdaq Bank Index falls, would show demand returning ahead of the report. Net new assets at or above $232.4 billion with investment banking growth well above 2% would do the same at the report itself.
What it trades with
Morgan Stanley's shares tend to trade with large US banks and with yields, so a Fed hike on 9 December 2026 would likely weigh on them whatever the company reports. Morgan Stanley's own analysts cited higher interest rates when downgrading Flagstar Bank to Underweight on 4 November 2026, company news reported, which shows the rate concern is live across bank research.
Wealth fees and equity trading also tie the business to stock markets, through client asset levels and trading activity. The Meta and Broadcom-Anthropic mandates add a link to AI spending and financing. A sharp pullback in AI borrowing would show up first in those financing mandates and in any related provisions.
Notes
- Morgan Stanley is a US global systemically important bank. Its buybacks and dividends depend on Federal Reserve stress-test capital requirements.
- Morgan Stanley reports quarterly results before the US market opens, in mid-January, April, July and October.
- Morgan Stanley's research arm publishes price targets on other companies; those headlines carry its name but are not news about its own business.
Sources
- Morgan Stanley (MS) · stockanalysis.com ·
- Morgan Stanley · morganstanley.com
- Morgan Stanley Reports Third Quarter 2026 Earnings Results · morningstar.com ·
- Morgan Stanley, JPMorgan turn cautious on private credit as redemptions surge · investmentnews.com